SCHEMBL29108787

SCHEMBL29108787

CC(C)c1cc(-c2cncnc2)n(CCc2c[nH]c3ccccc23)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 5/20 0.43
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ HTR1A P08908 4/20 0.41
▸ HTR2C P28335 3/20 0.40
▸ HTR2B P41595 2/20 0.40
▸ HTR1D P28221 2/20 0.40
▸ HTR1B P28222 2/20 0.40
▸ HTR7 P34969 2/20 0.40
▸ HTR6 P50406 2/20 0.40
▸ ADRB1 P08588 1/20 0.40
▸ ADRA2A P08913 1/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ HTR1E P28566 1/20 0.40
▸ SLC6A4 P31645 1/20 0.40
▸ SLC6A3 Q01959 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28358874 0.80 HTR2A (0.48) HTR2AMEN1KMT2ANPC1GAA
SCHEMBL22555840 0.80 CDK4 (0.47) HTR2AMEN1KMT2ANPC1GAA
SCHEMBL28358982 0.76 CDK4 (0.42) HTR2AMEN1KMT2ANPC1GAA
SCHEMBL28358885 0.74 CDK4 (0.43) HTR2AMEN1KMT2ANPC1GAA
SCHEMBL28358898 0.74 CDK4 (0.41) HTR2AMEN1KMT2ANPC1GAA
SCHEMBL28355005 0.72 CDK4 (0.41) HTR2AMEN1KMT2ANPC1GAA
SCHEMBL28359180 0.72 HTR1A (0.41) HTR2ARAB9AHTR1ASLC6A2SLC6A4
SCHEMBL28355198 0.70 CDK4 (0.44) HTR2AMEN1KMT2ANPC1GAA
SCHEMBL28355103 0.70 ALDH1A1 (0.48) HTR2AMEN1KMT2ANPC1GAA
SCHEMBL734207 0.70 HTR2A (0.52) HTR2AMEN1KMT2ANPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110831600-B Indole AHR inhibitors and uses thereof 医肯纳肿瘤学公司 2023-10-17 — — CN disclosed
Send feedback